Jia Jie Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 160.01 million compared to TWD 78.26 million a year ago. Net income was TWD 13.31 million compared to net loss of TWD 22.78 million a year ago.

Basic earnings per share from continuing operations was TWD 0.14 compared to basic loss per share from continuing operations of TWD 0.26 a year ago. Diluted earnings per share from continuing operations was TWD 0.14 compared to diluted loss per share from continuing operations of TWD 0.26 a year ago.